These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32651859)

  • 1. Multimodal evaluation of the cerebrovascular reserve in Neurofibromatosis type 1 patients with Moyamoya syndrome.
    D'Amico A; Ugga L; Cocozza S; Giorgio SMDA; Cicala D; Santoro C; Melis D; Cinalli G; Brunetti A; Pappatà S
    Neurol Sci; 2021 Feb; 42(2):655-663. PubMed ID: 32651859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged Mean Transit Time Detected by Dynamic Susceptibility Contrast Magnetic Resonance Imaging Predicts Cerebrovascular Reserve Impairment in Patients with Moyamoya Disease.
    Kawano T; Ohmori Y; Kaku Y; Muta D; Uekawa K; Nakagawa T; Amadatsu T; Kasamo D; Shiraishi S; Kitajima M; Kuratsu J
    Cerebrovasc Dis; 2016; 42(1-2):131-8. PubMed ID: 27088711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior Infarcts, Reactivity, and Angiography in Moyamoya Disease (PIRAMD): a scoring system for moyamoya severity based on multimodal hemodynamic imaging.
    Ladner TR; Donahue MJ; Arteaga DF; Faraco CC; Roach BA; Davis LT; Jordan LC; Froehler MT; Strother MK
    J Neurosurg; 2017 Feb; 126(2):495-503. PubMed ID: 26967789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience.
    Santoro C; Di Rocco F; Kossorotoff M; Zerah M; Boddaert N; Calmon R; Vidaud D; Cirillo M; Cinalli G; Mirone G; Giugliano T; Piluso G; D'Amico A; Capra V; Pavanello M; Cama A; Nobili B; Lyonnet S; Perrotta S
    Am J Med Genet A; 2017 Jun; 173(6):1521-1530. PubMed ID: 28422438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revascularization improves vascular hemodynamics - a study assessing cerebrovascular reserve and transit time in Moyamoya patients using MRI.
    Zhao MY; Armindo RD; Gauden AJ; Yim B; Tong E; Moseley M; Steinberg GK; Zaharchuk G
    J Cereb Blood Flow Metab; 2023 Nov; 43(2_suppl):138-151. PubMed ID: 36408536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and Long-Term MRI Assessed Hemodynamic Changes in Pediatric Moyamoya Patients After Revascularization.
    Zhao MY; Tong E; Duarte Armindo R; Fettahoglu A; Choi J; Bagley J; Yeom KW; Moseley M; Steinberg GK; Zaharchuk G
    J Magn Reson Imaging; 2024 Apr; 59(4):1349-1357. PubMed ID: 37515518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive method for mapping CVR in moyamoya disease using ASL-MRI.
    Noguchi T; Kawashima M; Nishihara M; Egashira Y; Azama S; Irie H
    Eur J Radiol; 2015 Jun; 84(6):1137-43. PubMed ID: 25816991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
    Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cerebrovascular reserve in patients with cerebrovascular diseases using resting-state MRI: A feasibility study.
    Taneja K; Lu H; Welch BG; Thomas BP; Pinho M; Lin D; Hillis AE; Liu P
    Magn Reson Imaging; 2019 Jun; 59():46-52. PubMed ID: 30849484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial transit artifacts observed by arterial spin labeling in Moyamoya disease.
    Ukai R; Mikami T; Nagahama H; Wanibuchi M; Akiyama Y; Miyata K; Mikuni N
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105058. PubMed ID: 32807463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-course analysis of brain perfusion single photon emission computed tomography using a three-dimensional stereotactic region-of-interest template in patients with moyamoya disease.
    Marushima A; Tsurushima H; Suzuki K; Nakai Y; Nemoto H; Matsumura A
    World Neurosurg; 2011; 76(3-4):304-10. PubMed ID: 21986429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Delay Arterial Spin Labeling Provides More Accurate Cerebral Blood Flow Measurements in Moyamoya Patients: A Simultaneous Positron Emission Tomography/MRI Study.
    Fan AP; Guo J; Khalighi MM; Gulaka PK; Shen B; Park JH; Gandhi H; Holley D; Rutledge O; Singh P; Haywood T; Steinberg GK; Chin FT; Zaharchuk G
    Stroke; 2017 Sep; 48(9):2441-2449. PubMed ID: 28765286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary and emerging magnetic resonance imaging methods for evaluation of moyamoya disease.
    Lehman VT; Cogswell PM; Rinaldo L; Brinjikji W; Huston J; Klaas JP; Lanzino G
    Neurosurg Focus; 2019 Dec; 47(6):E6. PubMed ID: 31786551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Moyamoya Syndrome in Pediatric Patients With Neurofibromatosis Type 1.
    Brosius SN; Vossough A; Fisher MJ; Lang SS; Beslow LA; George BJ; Ichord R
    Pediatr Neurol; 2022 Sep; 134():85-92. PubMed ID: 35849956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous phase-contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease.
    Ishii Y; Thamm T; Guo J; Khalighi MM; Wardak M; Holley D; Gandhi H; Park JH; Shen B; Steinberg GK; Chin FT; Zaharchuk G; Fan AP
    J Magn Reson Imaging; 2020 Jan; 51(1):183-194. PubMed ID: 31044459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging.
    Noguchi T; Kawashima M; Irie H; Ootsuka T; Nishihara M; Matsushima T; Kudo S
    Eur J Radiol; 2011 Dec; 80(3):e557-62. PubMed ID: 21315533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Intravascular Signal Arterial Transit Time Artifacts Have Negligible Effects on Cerebral Blood Flow and Cerebrovascular Reserve Capacity Measurement Using Single Postlabel Delay Arterial Spin-Labeling in Patients with Moyamoya Disease.
    Fahlström M; Lewén A; Enblad P; Larsson EM; Wikström J
    AJNR Am J Neuroradiol; 2020 Mar; 41(3):430-436. PubMed ID: 32115416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
    Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
    Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of delayed transit time on arterial spin labeling: correlation with dynamic susceptibility contrast perfusion magnetic resonance in moyamoya disease.
    Yun TJ; Sohn CH; Han MH; Kang HS; Kim JE; Yoon BW; Paeng JC; Choi SH; Kim JH; Song IC; Chang KH
    Invest Radiol; 2013 Nov; 48(11):795-802. PubMed ID: 23764569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.